Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1628732-62-6
2. Olinciguat [inn]
3. Iw-1701
4. Olinciguat [usan]
5. Iw1701
6. Pd5f4zxd21
7. (2r)-3,3,3-trifluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]amino]methyl]-2-hydroxypropanamide
8. Olinciguat (usan/inn)
9. Olinciguat [usan:inn]
10. Unii-pd5f4zxd21
11. Olinciguat [who-dd]
12. Chembl4297616
13. Schembl16081945
14. Gtpl10213
15. Bdbm321744
16. Db15238
17. Iw-1701iw-1701
18. Us10183021, Compound I-531
19. Ac-31551
20. Hy-109066
21. Cs-0033431
22. D11475
23. D87219
24. (2~{r})-3,3,3-trifluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]amino]methyl]-2-hydroxypropanamide
25. (2r)-3,3,3-trifluoro-2-(((5-fluoro-2-(1-((2-fluorophenyl)methyl)-5-(1,2-oxazol-3-yl)-1h-pyrazol-3-yl)pyrimidin-4-yl)amino)methyl)-2-hydroxypropanamide
26. Propanamide, 3,3,3-trifluoro-2-(((5-fluoro-2-(1-((2-fluorophenyl)methyl)-5-(3-isoxazolyl)-1h-pyrazol-3-yl)-4-pyrimidinyl)amino)methyl)-2-hydroxy-, (2r)-
| Molecular Weight | 509.4 g/mol |
|---|---|
| Molecular Formula | C21H16F5N7O3 |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 8 |
| Exact Mass | 509.12347821 g/mol |
| Monoisotopic Mass | 509.12347821 g/mol |
| Topological Polar Surface Area | 145 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 768 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of sickle cell disease
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
55
PharmaCompass offers a list of Olinciguat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Olinciguat manufacturer or Olinciguat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Olinciguat manufacturer or Olinciguat supplier.
PharmaCompass also assists you with knowing the Olinciguat API Price utilized in the formulation of products. Olinciguat API Price is not always fixed or binding as the Olinciguat Price is obtained through a variety of data sources. The Olinciguat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Olinciguat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olinciguat, including repackagers and relabelers. The FDA regulates Olinciguat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olinciguat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Olinciguat supplier is an individual or a company that provides Olinciguat active pharmaceutical ingredient (API) or Olinciguat finished formulations upon request. The Olinciguat suppliers may include Olinciguat API manufacturers, exporters, distributors and traders.
Olinciguat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Olinciguat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Olinciguat GMP manufacturer or Olinciguat GMP API supplier for your needs.
A Olinciguat CoA (Certificate of Analysis) is a formal document that attests to Olinciguat's compliance with Olinciguat specifications and serves as a tool for batch-level quality control.
Olinciguat CoA mostly includes findings from lab analyses of a specific batch. For each Olinciguat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Olinciguat may be tested according to a variety of international standards, such as European Pharmacopoeia (Olinciguat EP), Olinciguat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Olinciguat USP).
